Biotech Holdings Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Holdings

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dodger2 who wrote (14)	2/5/1997 10:42:00 PM
From: Robin Peterson	of 224

Hi Darrin, The company told me they had had numerous enquiries from U.S. investors and brokers for more info. Compared with U.S. biotech cos. the enquirers remarked that BIO was cheap. There really hasn't been that much demand - the stock has moved up on low volume. The story about the N.Y. trip is true, but it's not like they sign an agreement one day and announce it the next. A licensing agreement will mean trial design and satisfactory results. It comes down to the same simple point - do they have the drug? If they don't then the large multi-national would have said good-bye by now. I have to admit though the it's difficult not to get caught up in the volatility. I keep reminding myself they need a $4.00 stock price for 3 months to get a NASDAQ listing, otherwise they're wasting $40,000 in costs. Also the employee options are not exercisable until $3.30 has been achieved for 3 months. Bob Rieveley imagines himself in the Bill Gates mould (bear with me on this) and plans not to sell stock but to pay out dividends. We shall see. Take care, Robin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next